Gilead presses HIV drug fraud in court, wins freeze of 'kingpin' assets

Gilead Sciences says it's dealing with a massive fraud scheme and was scammed out of millions of dollars. Now, that saga is playing out in a Miami court.

Truvada, the company's original therapy for preexposure prophylaxis (PrEP), was the first of it kind when it entered the market in 2012. The drug works as a preventive treatment for those at risk of contracting HIV. Through its Advancing Access Medication Assistance Program (MAP), Gilead provides free drug to uninsured patients. With MAP, eligible patients can receive Truvada and the follow-up med Descovy.